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Introduction
It is widely held that autonomous or tertiary hyperparathyroidism often complicates chronic renal failure, particularly in patients receiving maintenance haemodialysis.' 2 This is based on the significant numbers of patients receiving haemodialysis who have a combination of hypercalcaemia and raised serum parathyroid hormone concentrations and are intolerant of vitamin D. ' In the past these patients have usually been subjected to total or subtotal parathyroidectomy in an effort to restore vitamin D responsiveness. ' It has always been difficult to predict which patients required parathyroidectomy, however, since some patients apparently fulfil accepted criteria for parathyroid "autonomy" but nevertheless respond to vitamin D. 4 It would clearly be advantageous to identify patients with true autonomy (or at least a large degree of non-suppressibility) of the parathyroid glands at an early stage, since parathyroidectomy is the treatment of choice in these patients. Probably such an approach would prevent some of the problems that accompany prolonged tertiary hyperparathyroidism. Recently we have shown that acute responsiveness of the parathyroids to changes in serum calcium concentration is maintained in renal failure and that it is the rate and direction of change in serum calcium rather than the absolute change that determines the magnitude of the response of parathyroid hormone.' Long term suppression of serum parathyroid hormone may be produced by treatment with 1,25-dihydroxyvitamin D, (1,25(OH),D,),78 although patients may vary in how well they respond to such treatment. 9 In this paper we define the relation between acute and chronic responsiveness of the parathyroids to appropriate stimuli in end stage renal failure and propose a simple method of identifying those patients in whom early surgical treatment of secondary hyperparathyroidism is advisable.
Patients and methods
We conducted two separate studies.
ACUTE STUDIES
Twelve patients aged 20-62 years (mean 35-2 (SD 13-1) years) who had been receiving haemodialysis for two to 68 months (25-8 (SD 26 9) months) and had not previously been given vitamin D were infused with elemental calcium 4 mg/kg/h (as 10%0 calcium gluconate in 5 dextrose) over four hours. All patients were studied immediately before a scheduled dialysis session, as described. 6 Serum for measurement of parathyroid hormone concentration was separated within one hour of collection and stored at -20°C until analysed. The parathyroid hormone assays were performed at the Middlesex Hospital, London, using two recently developed region specific homologous immunoradiometric assays. One assay'0 was highly specific for the biologically active amino terminal region of human parathyroid hormone, while the other" was specific for the immunologically active but biologically inactive carboxy terminal region of human parathyroid hormone. This distinction is of considerable importance, since high concentrations of circulating (but inactive) fragments of carboxy terminal parathyroid hormone constitute the major part of the total serum parathyroid hormone in chronic renal failure. of output of parathyroid hormone cannotbe achieved at anacceptable serum calcium concentration. Support for this hypothesis was provided by Gittes and Radde, who transplanted a large number of normal parathyroid glands into rats, which promptly developed hypercalcaemia." These glands were presumably responsive to normal regulatory mechanisms but still failed to suppress, suggesting that simply increasing total parathyroid mass will lead to a state of functional hyperparathyroidism that is only partly suppressible. The response of serum carboxy terminal parathyroid hormone during calcium infusion was more variable, and the concentration rose during the first hour in five patients. There was a weak inverse correlation between percentage fall in carboxy terminal parathyroid hormone and basal serum calcium concentration. The reason for the discrepancy in the results of changes in amino and carboxy terminal parathyroid hormone during calcium infusion is complex. Fragments of carboxy terminal parathyroid hormone are cleared slowly in end stage renal failure and constitute a major portion of total parathyroid hormone measured by unselective or carboxy terminal assays. '2 An assay specific for amino terminal parathyroid hormone may reflect more accurately changes in intact 1-84 parathyroid hormone concentrations and is thus more appropriate for detecting both acute and chronic alterations in biologically active concentrations of parathyroid hormone in renal failure. We conclude that the responsiveness of the parathyroid glands to acute hypercalcaemia is retained to a variable extent in end stage renal failure and may be assessed using an appropriate assay for parathyroid hormone. Apparently changes in amino terminal parathyroid hormone provide a more reliable and sensitive indicator of acute parathyroid suppressibility than do changes in carboxy terminal parathyroid hormone.
Identifying patients with non-suppressible parathyroid glands is of considerable clinical importance, since it is these patients who are likely to benefit most from total or subtotal parathyroidectomy. Comparing responsiveness of amino terminal parathyroid hormone to calcium infusion and percentage fall in concentration of the hormone after treatment with 1,25(OH)2D, helps to provide an answer, since there was a significant correlation between percentage suppression of amino terminal parathyroid hormone during calcium infusion and percentage fall in amino terminal parathyroid hormone after prolonged administration of 1,25(OH)2D,. These data indicate that patients with less than 30% suppression of amino terminal parathyroid hormone during calcium infusion will fail to respond to 1,25(OH)2 D3. The close relation between fall in amino terminal parathyroid hormone during calcium infusion and basal serum calcium concentration suggests that it may be possible to identify those patients likely to respond to 1,25(OH)2D, simply from their serum calcium concentrations, thus obviating the need for infusion. Nevertheless, although this may prove valid for patients with severe hypercalcaemia (>3 0 mmol/l; > 12-0 mg/100 ml), the response to calcium infusion indicates that patients with mild hypercalcaemia (2-6-3-0 mmol/l; 10O4-12-0 mg/100 ml) may still respond favourably to 1,25(OH)2D.. Thus preliminary infusion of calcium may be of value in predicting which patients will respond to long term treatment with 1,25(OH),D, and which patients would benefit most from early parathyroidectomy.
